Therapeutic nuclear medicine: Dose-effects for a novel 177-Lu based treatment of non-Hodgkin lymphoma (South-Eastern Norway Regional Health Authority Research Grant, 2017-2020), Simulation tools and quantitative 90-Y PET/CT for Selective Internal Radiation Therapy (South-Eastern Norway Regional Health Authority Innovation Grant), Dosimetry-based treatment planning of 131-I therapy, Theranostic radiopharmaceuticals for metastatic cancer -focusing on targeted alpha therapy (South-Eastern Norway Regional Health Authority Grant, 2020-2022)
Oncological assessment: Quantitative PET parameters as predictors for patient outcome (part of different lymphoma trials), development of radiomics feature software, novel PET tracers for multiple myeloma assessments, and various technical projects related to image reconstruction and analyses
Bakke KM, Meltzer S, Grøvik E, Negård A, Holmedal SH, Mikalsen LTG, Færden AE, Lyckander LG, Julbø FMI, Bjørnerud A, Gjesdal KI, Ree AH, Redalen KR(2023) Imaging the tumour microenvironment in rectal cancer: Decline in tumour blood flow during radiotherapy predicts good outcome Phys Imaging Radiat Oncol, 25, 100417 DOI 10.1016/j.phro.2023.100417, PubMed 36718357
Cicone F, Santo G, Bodet-Milin C, Cascini GL, Kraeber-Bodéré F, Stokke C, Kolstad A(2023) Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update Semin Nucl Med(in press) DOI 10.1053/j.semnuclmed.2022.12.006, PubMed 36635112
Larsen CK, Galli E, Duchenne J, Aalen JM, Stokke C, Fjeld JG, Degtiarova G, Claus P, Gheysens O, Saberniak J, Sirnes PA, Lyseggen E, Bogaert J, Kongsgaard E, Penicka M, Voigt JU, Donal E, Hopp E, Smiseth OA(2022) Scar imaging in the dyssynchronous left ventricle: Accuracy of myocardial metabolism by positron emission tomography and function by echocardiographic strain Int J Cardiol, 372, 122-129 DOI 10.1016/j.ijcard.2022.11.042, PubMed 36460211